Krupa Parikh

Washington, D.C.
  • 555 Eleventh Street, NW
  • Suite 1000
  • Washington, D.C. 20004-1304
  • USA
Profile Experience

Krupa Parikh is an associate in the Washington, D.C. office of Latham & Watkins and a member of the Intellectual Property Litigation Practice.

Ms. Parikh's practice focuses on patent litigation, particularly for clients in the pharmaceutical, life sciences, and biotechnology industries. She has experience in Hatch-Waxman matters and biosimilar patent disputes under the Biologics Price Competition and Innovation Act (BPCIA). She is also experienced in guiding clients through post-grant proceedings, including inter partes review (IPR) proceedings, before the Patent Trial and Appeal Board (PTAB).

Ms. Parikh earned her JD from The George Washington University Law School, where she graduated with honors. She holds her BS in Chemical and Biomolecular Engineering from Cornell University, where she served as Editor-in-Chief of the Cornell University Pre-Law Journal.

Prior to joining Latham, Ms. Parikh was an associate at another international law firm where she served as a leader of their diversity committee. She also served as a research associate in the research and development arm of a global drug manufacturer.

  • “Timing Considerations When Settling Post-Grant Proceedings: How Late is Too Late?,” NYIPLA’s The Report (2017)
  • “The Changing Landscape of Patent Licensing after the Leahy-Smith America Invents Act,” The America Bar Association’s Landslide (2016)

Ms. Parikh’s experience includes representation of:

  • Fresenius Kabi USA, LLC v. Shire Orphan Therapies LLC: Fresenius in a Hatch-Waxman case related to peptides for treating hereditary angioedema*
  • Celltrion, Inc. v. Genetech, Inc.: Biosimilar applicant Celltrion in multiple IPR proceedings and co-pending BPCIA litigation on patents relating to cancer treatment*
  • Coalition for Affordable Drugs VIII LLC v. Aegerion Pharmaceuticals, Inc.: Aegerion in multiple IPR proceedings relating to treatment of homozygous familial hypercholesterolemia*
  • IDEXX Labs., Inc. v Charles River Labs., Inc.: Charles River Labs. in a patent infringement case and three co-pending IPR proceedings relating to rodent colony screening*

*Matter handled prior to joining Latham

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.